| Previous Close | 35.97 |
| Open | 36.10 |
| Bid | 35.75 x 300 |
| Ask | 35.99 x 200 |
| Day's Range | 35.77 - 36.12 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 203 |
| Avg. Volume | 16,874,860 |
| Market Cap | 213.87B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.31 |
| EPS (TTM) | 1.37 |
| Earnings Date | Oct 31, 2017 |
| Dividend & Yield | 1.28 (3.61%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | 37.85 |
- Financial Times•44 minutes ago
[$$] Pfizer tests new way of putting more drugs on trial
Pfizer has backed a new drug development company with the task of shepherding four of its experimental medicines through clinical trials, in an unusual deal designed to prevent promising products from ...
- TheStreet.com•2 days ago
The 6 Medications Being Used to Tackle the Opioid Epidemic
The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
- Fortune•3 days ago
Healthcare Stocks Soar After McCain Rejects Obamacare Repeal
The Graham Cassidy bill appears dead, but the stock market has found new life.
